Completed PHASE2 INTERVENTIONAL 4-arm NCT01349803

PT003 MDI Cardiovascular Safety Study

A Randomized, Double-blind, Parallel Group, 14-day, Multi-Center Study to Evaluate the Safety of PT003, PT005, PT001 and Foradil® Aerolizer® (12 µg, Open Label) as Evaluated by Holter Monitoring, in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Sponsor: Pearl Therapeutics, Inc.

Conditions Chronic Obstructive Pulmonary Disease

Interventions Formoterol Fumarate 12 μg (Foradil® Aerolizer®) PT001 MDI PT003 MDI PT005 MDI

Updated 6 times since 2017 Last updated: Dec 7, 2016 Started: May 31, 2011 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Chronic Obstructive Pulmonary Disease, this trial is completed. The trial is conducted by Pearl Therapeutics, Inc. and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pearl Therapeutics, Inc.

Data source: Pearl Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Caboolture, Australia , Caversham, New Zealand , Dawpark, Australia , Fullerton, United States , Glebe, Australia , Glendale, United States , Heidelberg, Australia , Lafayette, United States , Livonia, United States , Los Angeles, United States and 10 more locations